Experimental Groups | Â | Blood | Â | BAL Fluid | |
---|---|---|---|---|---|
 | TLC (per μl) | Absolute number of Neutrophils (%) | Lymphocytes (%) | TLC (per μl) | Absolute number of Neutrophils (%) |
Control | 3699.16 ± 199.1a | 28 ± 1.06a | 72 ± 1.06a | 157.83 ± 3.49a | 21.83 ± 1.92a |
LPS | 4951.66 ± 219.7b | 39.5 ± 1.05b | 60.5 ± 1.05b | 437 ± 15.52b | 35.33 ± 1.72b |
High dose of 2,4-D | 4748.83 ± 289.8b | 36.16 ± 1.83b | 63.83 ± 1.83b | 329.83 ± 28.72c | 30.16 ± 1.16c |
Low dose of 2,4-D | 4483.33 ± 162.6a | 34.66 ± 2.18b | 65.33 ± 2.18b | 303.83 ± 12.1c | 30.5 ± 1.64c |
High dose of 2,4-D + LPS | 5826.66 ± 160.5c | 51.83 ± 0.98b | 48.16 ± 0.98b | 492.16 ± 15.61b | 42.16 ± 1.66b |
Low dose of 2,4-D + LPS | 5100.83 ± 136.9b | 45.66 ± 3.52b | 54.33 ± 3.52b | 432.33 ± 17.8b | 38.83 ± 2.18b |